Under The Influence: Prediction Markets Are Harnessing Modern Joe Camels
Brant James, Ingame
Robins et al. v. Lemme Inc.
25STCV04635, California state court – Los Angeles
(Feb. 2025)
Lemme GLP-1 Daily Capsules
Misleadingly marketing that products will reduce hunger and provide weight management benefits when clinical evidence does not support such claims
Misleadingly marketing that the ingredients in the products have been clinically tested when the combination of ingredients in the supplement has not been clinically tested
Preventing consumers from leaving negative performance reviews of the supplement on its website
Pending
Brant James, Ingame
Company becomes the latest to leave the industry.
The FTC’s Negative Option Rule do-over – and what’s at stake.
Be wary of questionable and deceptive claims in origin stories.
Mounting lawsuits accuse Meta of breaking privacy promises.